oncology

Exclusive By Matthew Herper

Tempus unveils prototype cube that talks back to oncologists

Biotech By Kate Sheridan

‘Every man and his dog’ does cell therapy. Vor’s new CEO says the company wants to be different

Politics By Nicholas Florko

As CAR-T changes lives, Medicare’s top official explains why it’s proving so hard to pay for it

Biotech By Damian Garde

Q&A: Bristol-Myers’ top scientist on the future of cancer care

Biotech By Meghana Keshavan

Q&A: Repurposing existing drugs for new uses in cancer — for no profit

Health By Sheila Kaplan

FDA warns against widely used ovarian cancer screening test

Health By Dylan Scott

Top scientists lay out sweeping recommendations for ‘moonshot’ against cancer

Pharmalot By Ed Silverman

Most experts who develop cancer treatment guidelines have ties to industry